Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People > = 18 Years Old With Advanced Soft Tissue Sarcoma

Conditions:   Metastatic Extraskeletal Myxoid Chondrosarcoma;   Metastatic Leiomyosarcoma;   Metastatic Liposarcoma;   Metastatic Undifferentiated Pleomorphic Sarcoma Interventions:   Procedure: Biopsy;   Procedure: Biospecimen Collection;   Drug: Cabozantinib;   Procedure: Computed Tomography;   Biological: Ipilimumab;   Procedure: Magnetic Resonance Imaging;   Biological: Nivolumab Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials